|
No. |
Topic |
Summary |
Pages |
9900
| Improving the PK/PO properties of Biopharmaceuticals | - | 64 |
9901
| Pre-Clinical Aspects in R&D of Therapeutics Proteins of the Second Generation | - | 46 |
9902
| Development of Biotech Formulations | - | 20 |
9904
| High throughput Formulation DEvelopment for Biopharmaceutical | - | 50 |
9905
| Process DEvelopment applying Disposables Technology | - | 43 |
9906
| Case Study: New Antibody Product DEvelopment | - | 41 |
9907
| Process Transfer - the critical step between Development and Validation | - | 45 |
9908
| PAT IMplementation | - | 26 |
9909
| Multidimensional quantified Risk management | - | 41 |
9910
| New Technologies / Regulatory Developments in Pharma PDA refection | - | 46 |
9911
| Linking Regulatory CMC to the future | - | 37 |
9912
| Life Circle Management from Visit to dual chamber springe | - | 51 |
10486
| Overall Equipment - Efficiency in Aseptic Fill & Finish | - | 25 |
10487
| Isolator vs. RABS - What, when andf how? | - | 33 |
